Distinct Phospho-TDP-43 brain distribution in two cases of FTD, one associated with ALS

Distinct Phospho-TDP-43 brain distribution in two cases of FTD, one associated with ALS

ABSTRACT INTRODUCTION: TDP-43 is an intranuclear protein involved in many cellular processes. When altered, it shows a change in pattern of distribution, as well as in functioning, throughout the Central Nervous System structures. Frontotemporal Lobar Degeneration (FTLD) and Amyotrophic Lateral Scl...

Full description

Bibliographic Details
Main Authors:	Álvaro C.B. Guedes, Ricardo Santin, André S.R. Costa, Keli C. Reiter, Arlete Hilbig, Liana L. Fernandez
Format:	Article
Language:	English
Published:	Associação Neurologia Cognitiva e do Comportamento
Series:	Dementia & Neuropsychologia
Subjects:	TDP-43 frontotemporal dementia amyotrophic lateral sclerosis neuropathology
Online Access:	http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1980-57642017000300249&lng=en&tlng=en

Similar Items

Immunotherapy targeting the C-terminal domain of TDP-43 decreases neuropathology and confers neuroprotection in mouse models of ALS/FTD
by: Tariq Afroz, et al.
Published: (2023-04-01)

Targeting the TDP-43 low complexity domain blocks spreading of pathology in a mouse model of ALS/FTD
by: Elodie Chevalier, et al.
Published: (2024-10-01)

TDP-43 Proteinopathy Specific Biomarker Development
by: Isabell Cordts, et al.
Published: (2023-02-01)

Heterogeneity of cortical pTDP-43 inclusion morphologies in amyotrophic lateral sclerosis
by: Rachel H. Tan, et al.
Published: (2023-11-01)

Cyclin F can alter the turnover of TDP-43
by: Stephanie L. Rayner, et al.
Published: (2024-03-01)

Stimulating VAPB-PTPIP51 ER-mitochondria tethering corrects FTD/ALS mutant TDP43 linked Ca2+ and synaptic defects
by: Andrea Markovinovic, et al.
Published: (2024-02-01)

Sustained therapeutic benefits by transient reduction of TDP-43 using ENA-modified antisense oligonucleotides in ALS/FTD mice
by: Toshihide Takeuchi, et al.
Published: (2023-03-01)

TDP-43 and Phosphorylated TDP-43 Levels in Paired Plasma and CSF Samples in Amyotrophic Lateral Sclerosis
by: Yuting Ren, et al.
Published: (2021-06-01)

Cytoplasmic Expression of the ALS/FTD-Related Protein TDP-43 Decreases Global Translation Both in vitro and in vivo
by: Santiago E. Charif, et al.
Published: (2020-12-01)

Both cytoplasmic and nuclear accumulations of the protein are neurotoxic in Drosophila models of TDP-43 proteinopathies
by: Laetitia Miguel, et al.
Published: (2011-02-01)

TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex
by: Stephanie L. Rayner, et al.
Published: (2022-06-01)

A panel of TDP-43-regulated splicing events verifies loss of TDP-43 function in amyotrophic lateral sclerosis brain tissue
by: Maize C. Cao, et al.
Published: (2023-09-01)

TDP-43 mislocalization drives neurofilament changes in a novel model of TDP-43 proteinopathy
by: Rachel Atkinson, et al.
Published: (2021-02-01)

TDP-43 and Limbic-Predominant Age-Related TDP-43 Encephalopathy
by: Lumi Zhang, et al.
Published: (2020-01-01)

Alterations in stress granule dynamics driven by TDP-43 and FUS: A link to pathological inclusions in ALS?
by: Anais eAulas, et al.
Published: (2015-10-01)

Evidence of cerebellar TDP-43 loss of function in FTLD-TDP
by: Sarah Pickles, et al.
Published: (2022-07-01)

Isolation and characterization of antibody fragments selective for human FTD brain derived TDP-43 variants
by: Lalitha Venkataraman, et al.
Published: (2020-09-01)

The Pathobiology of TDP-43 C-Terminal Fragments in ALS and FTLD
by: Britt A. Berning, et al.
Published: (2019-04-01)

Nuclear import receptors are recruited by FG-nucleoporins to rescue hallmarks of TDP-43 proteinopathy
by: Bilal Khalil, et al.
Published: (2022-12-01)

Body Complexion and Circulating Lipids in the Risk of TDP-43 Related Disorders
by: Noelia Esteban-García, et al.
Published: (2022-03-01)

Targeting the glycine-rich domain of TDP-43 with antibodies prevents its aggregation in vitro and reduces neurofilament levels in vivo
by: Henrick Riemenschneider, et al.
Published: (2023-07-01)

Loss of TDP-43 function contributes to genomic instability in amyotrophic lateral sclerosis
by: Minggang Fang, et al.
Published: (2023-10-01)

ALS-linked TDP-43M337V knock-in mice exhibit splicing deregulation without neurodegeneration
by: Seiji Watanabe, et al.
Published: (2020-01-01)

Early cognitive/social deficits and late motor phenotype in conditional wild-type TDP-43 transgenic mice.
by: Julio Armando Alfieri, et al.
Published: (2016-12-01)

Structural polymorphism of the low-complexity C-terminal domain of TDP-43 amyloid aggregates revealed by solid-state NMR
by: Jayakrishna Shenoy, et al.
Published: (2023-03-01)

Low T-cell reactivity to TDP-43 peptides in ALS
by: Swetha Ramachandran, et al.
Published: (2023-07-01)

A C-Terminally Truncated TDP-43 Splice Isoform Exhibits Neuronal Specific Cytoplasmic Aggregation and Contributes to TDP-43 Pathology in ALS
by: Marc Shenouda, et al.
Published: (2022-06-01)

TDP-43 pathology is sufficient to drive axon initial segment plasticity and hyperexcitability of spinal motoneurones in vivo in the TDP43-ΔNLS model of Amyotrophic Lateral Sclerosis
by: Svetlana Djukic, et al.
Published: (2025-02-01)

Clinical and neuropathological features of ALS/FTD with TIA1 mutations
by: Veronica Hirsch-Reinshagen, et al.
Published: (2017-12-01)

Transcriptomic Analysis of Zebrafish TDP-43 Transgenic Lines
by: Alexandra Lissouba, et al.
Published: (2018-12-01)

Progranulin haploinsufficiency mediates cytoplasmic TDP-43 aggregation with lysosomal abnormalities in human microglia
by: Wonjae Sung, et al.
Published: (2024-02-01)

Modulation of synaptic plasticity, motor unit physiology, and TDP-43 pathology by CHCHD10
by: Tian Liu, et al.
Published: (2022-07-01)

Movement disorders are linked to TDP-43 burden in the substantia nigra of FTLD-TDP brain donors
by: Luigi Fiondella, et al.
Published: (2023-04-01)

Slow motor neurons resist pathological TDP-43 and mediate motor recovery in the rNLS8 model of amyotrophic lateral sclerosis
by: Seong Kwon Hur, et al.
Published: (2022-05-01)

Nuclear-import receptors as gatekeepers of pathological phase transitions in ALS/FTD
by: Bilal Khalil, et al.
Published: (2024-01-01)

Emerging perspectives of synaptic biomarkers in ALS and FTD
by: Karrthik Krishnamurthy, et al.
Published: (2024-01-01)

Altered microRNA expression in frontotemporal lobar degeneration with TDP-43 pathology caused by progranulin mutations
by: Kocerha Jannet, et al.
Published: (2011-10-01)

Patients with sporadic FTLD exhibit similar increases in lysosomal proteins and storage material as patients with FTD due to GRN mutations
by: Skylar E. Davis, et al.
Published: (2023-04-01)

c-Abl Regulates the Pathological Deposition of TDP-43 via Tyrosine 43 Phosphorylation
by: Saebom Lee, et al.
Published: (2022-12-01)

Distinct molecular patterns of TDP-43 pathology in Alzheimer’s disease: relationship with clinical phenotypes
by: Sandra O. Tomé, et al.
Published: (2020-04-01)